Elite in Eosinophilic Asthma

Andrew N. Gow-Menzies

Guy's And St Thomas' NHS Foundation Trust, 
London, ENG, GB 
Elite in Eosinophilic Asthma
Guy's And St Thomas' NHS Foundation Trust, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Andrew Gow-Menzies practices in London, United Kingdom. Mr. Gow-Menzies is rated as an Elite expert by MediFind in the treatment of Eosinophilic Asthma. His top areas of expertise are Asthma, Eosinophilic Asthma, Allergic Bronchopulmonary Aspergillosis, Hypereosinophilic Syndrome, and Endoscopy.

His clinical research consists of co-authoring 178 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Eosinophilic Asthma.

Gender
Male

Locations

Guy's And St Thomas' NHS Foundation Trust, London, ENG SW36NP, United Kingdom
Other Locations
Cambridge, ENG, United Kingdom
Harefield, ENG, United Kingdom
Brompton, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter Variable Length Study to Assess the Efficacy and Safety of PT010 Relative to PT009 and Symbicort® in Adult and Adolescent Participants With Inadequately Controlled Asthma
A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter Variable Length Study to Assess the Efficacy and Safety of PT010 Relative to PT009 and Symbicort® in Adult and Adolescent Participants With Inadequately Controlled Asthma
Enrollment Status: Completed
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Budesonide, Glycopyrronium, Formoterol Fumarate
Study Phase: Phase 3
National Validation and Sensitivity to Change of a Scale to Measure Quality of Life in Patients With Severe Asthma
National Validation and Sensitivity to Change of a Scale to Measure Quality of Life in Patients With Severe Asthma
Enrollment Status: Completed
Publish Date: January 06, 2021
A Randomised Pragmatic Trial Of Corticosteroid Optimisation In Severe Asthma Using A Composite Biomarker Algorithm To Adjust Corticosteroid Dose Versus Standard Care
A Randomised Pragmatic Trial Of Corticosteroid Optimisation In Severe Asthma Using A Composite Biomarker Algorithm To Adjust Corticosteroid Dose Versus Standard Care
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trials

178 Total Publications

Efficacy and clinical remission in patients with severe asthma and blood eosinophil counts ≥150 cells/μl treated with benralizumab: a sub-analysis of the Phase 3 MIRACLE study
Efficacy and clinical remission in patients with severe asthma and blood eosinophil counts ≥150 cells/μl treated with benralizumab: a sub-analysis of the Phase 3 MIRACLE study
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: October 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gow-Menzies's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile